Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Recombinant human acid ceramidase

EU orphan designation number: EU/3/14/1243   
Active ingredient: Recombinant human acid ceramidase
Indication: Treatment of Farber disease
Sponsor: Enzyvant Farber Ireland Limited
9 Exchange Place , International Finance Service Centre, Dublin 1, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/02/2014 Orphan designation EMA/OD/167/13 (2014)1317 of 21/02/2014
8/04/2015 Transfer of orphan designation EMA/OD/167/13/T/01 (2015)2365 of 1/04/2015
12/06/2017 Transfer of orphan designation EMA/OD/167/13/T/02 (2017)4085 of 8/06/2017
23/04/2018 Change of name and/or address of sponsor